Compare ETFs: IBB vs. LON:XDWH
IBB
LON:XDWH
Comparison
Average Return
In the past year, IBB returned a total of 36.19%, which is significantly higher than LON:XDWH's 23.29% return. Over the past 10 years, IBB has had annualized average returns of 8.68%, compared to 10.19% for LON:XDWH. These numbers are adjusted for stock splits and assume dividends are reinvested.
Top 25 Holdings
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | GILD | Gilead Sciences, Inc. | 8.79% |
| 2 | AMGN | Amgen Inc. | 8.22% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.69% |
| 4 | MRNA | Moderna, Inc. | 6.61% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 6.13% |
| 6 | ARGX | argenx SE | 3.59% |
| 7 | NTRA | Natera, Inc. | 2.90% |
| 8 | RVMD | Revolution Medicines, Inc. | 2.59% |
| 9 | BIIB | Biogen Inc. | 2.51% |
| 10 | ONC | BeOne Medicines AG | 2.36% |
| 11 | ILMN | Illumina, Inc. | 2.24% |
| 12 | GMAB | Genmab A/S | 2.08% |
| 13 | INSM | Insmed Incorporated | 1.68% |
| 14 | INCY | Incyte Corporation | 1.65% |
| 15 | UTHR | United Therapeutics Corporation | 1.62% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.43% |
| 17 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.40% |
| 18 | EXEL | Exelixis, Inc. | 1.16% |
| 19 | NBIX | Neurocrine Biosciences, Inc. | 1.14% |
| 20 | CRL | Charles River Laboratories International, Inc. | 1.12% |
| 21 | ASND | Ascendis Pharma A/S | 1.08% |
| 22 | MEDP | Medpace Holdings, Inc. | 1.02% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 0.92% |
| 24 | HALO | Halozyme Therapeutics, Inc. | 0.78% |
| 25 | TECH | Bio-Techne Corporation | 0.76% |
| View IBB holdings | |||
| LON:XDWH - Xtrackers MSCI World Health Care UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | LLY | Eli Lilly and Company | 11.11% |
| 2 | JNJ | Johnson & Johnson | 7.64% |
| 3 | ABBV | AbbVie Inc. | 5.54% |
| 4 | MRK | Merck & Co., Inc. | 4.30% |
| 5 | UNH | UnitedHealth Group Incorporated | 4.00% |
| 6 | SWX: ROP | Roche Holding AG | 3.52% |
| 7 | SWX: NOVN | Novartis AG | 3.16% |
| 8 | TMO | Thermo Fisher Scientific Inc. | 3.01% |
| 9 | LON: AZN | AstraZeneca PLC | 2.96% |
| 10 | AMGN | Amgen Inc. | 2.73% |
| 11 | GILD | Gilead Sciences, Inc. | 2.22% |
| 12 | ABT | Abbott Laboratories | 2.07% |
| 13 | PFE | Pfizer Inc. | 1.95% |
| 14 | ISRG | Intuitive Surgical, Inc. | 1.73% |
| 15 | DHR | Danaher Corporation | 1.69% |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 1.59% |
| 17 | BMY | Bristol-Myers Squibb Company | 1.53% |
| 18 | CPH: NOVO.B | Novo Nordisk A/S | 1.49% |
| 19 | MDT | Medtronic plc | 1.32% |
| 20 | CVS | CVS Health Corporation | 1.31% |
| 21 | MCK | McKesson Corporation | 1.20% |
| 22 | LON: GSK | GSK plc | 1.18% |
| 23 | SYK | Stryker Corporation | 1.14% |
| 24 | EPA: SAN | Sanofi | 1.08% |
| 25 | ELV | Elevance Health, Inc. | 1.01% |
| View LON:XDWH holdings | |||